HeartFlow, Inc. (HTFL)

NASDAQ: HTFL · Real-Time Price · USD
24.83
+0.33 (1.35%)
At close: Apr 2, 2026, 4:00 PM EDT
24.99
+0.16 (0.64%)
After-hours: Apr 2, 2026, 7:47 PM EDT
Market Cap2.13B
Revenue (ttm)176.03M +39.9%
Net Income-116.79M
EPS-3.17
Shares Out 85.76M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,818,095
Open24.03
Previous Close24.50
Day's Range23.19 - 25.02
52-Week Range20.13 - 41.22
Betan/a
AnalystsStrong Buy
Price Target38.20 (+53.85%)
Earnings DateMay 10, 2026

About HTFL

HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases the United States and worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient’s heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart’s arteries. The company provides Heartflow RoadMap Analysis that offers an intuitive anatomic visualization of the coronary arteries; Heart... [Read more]

Sector Healthcare
IPO Date Aug 8, 2025
Employees 843
Stock Exchange NASDAQ
Ticker Symbol HTFL
Full Company Profile

Financial Performance

In 2025, HeartFlow's revenue was $176.03 million, an increase of 39.92% compared to the previous year's $125.81 million. Losses were -$116.79 million, 21.1% more than in 2024.

Financial Statements

Analyst Summary

According to 5 analysts, the average rating for HTFL stock is "Strong Buy." The 12-month stock price target is $38.2, which is an increase of 53.85% from the latest price.

Price Target
$38.2
(53.85% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

HeartFlow: Getting Into The Flow

HeartFlow delivered 40% sales growth in 2025, with revenue surpassing $176 million and strong Q4 momentum. 2026 guidance targets 25% revenue growth to $218–222 million, with gross margins rising to 80...

16 days ago - Seeking Alpha

HeartFlow, Inc. (HTFL) Q4 2025 Earnings Call Transcript

HeartFlow, Inc. (HTFL) Q4 2025 Earnings Call Transcript

17 days ago - Seeking Alpha

Heartflow Builds Evidence Base Across the Heart Disease Care Continuum, From Precision Risk Stratification to CT-Guided Intervention Planning

Three presentations at ACC reinforce Heartflow's AI-powered technology predicts MACE, drives superior lipid outcomes and results in cost-effective care   First patient enrolled in p ioneering N AVIGAT...

20 days ago - GlobeNewsWire

HeartFlow, Inc. (HTFL) Presents at Morgan Stanley Technology, Media & Telecom Conference 2026 Transcript

HeartFlow, Inc. (HTFL) Presents at Morgan Stanley Technology, Media & Telecom Conference 2026 Transcript

4 weeks ago - Seeking Alpha

Heartflow to Participate in the Morgan Stanley Technology, Media & Telecom Conference

MOUNTAIN VIEW, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced that members of mana...

6 weeks ago - GlobeNewsWire

2025 U.S. IPO Performance Starts With A Roar And Ends With A Whimper

2025 US IPOs emerged out of a tumultuous April with strong price momentum going into the summer. US IPOs under $100 million in proceeds continued to perform poorly in 2025 after also struggling in 202...

6 weeks ago - Seeking Alpha

Heartflow to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026

MOUNTAIN VIEW, Calif., Feb. 13, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced it will release fina...

7 weeks ago - GlobeNewsWire

Baron Opportunity Fund Q4 2025 Portfolio Activity

We invest in secular growth and innovative businesses across all market capitalizations, with the bulk of the portfolio landing in the large-cap zone. We recently initiated a position in Axon Enterpri...

7 weeks ago - Seeking Alpha

HeartFlow, Inc. (HTFL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

HeartFlow, Inc. (HTFL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

2 months ago - Seeking Alpha

Heartflow Plaque Analysis Now Covered by Aetna Insurance Plans Nationwide and for the Majority of Insured Lives in the U.S.

MOUNTAIN VIEW, Calif., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced Heartflow Plaque Ana...

3 months ago - GlobeNewsWire

Heartflow to Participate in the 44th Annual J.P. Morgan Healthcare Conference

MOUNTAIN VIEW, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in artificial intelligence (AI) technology for coronary artery disease (CAD), today anno...

3 months ago - GlobeNewsWire

Heartflow Plaque Analysis Now Supported by Scientific Statements From American College of Cardiology and American Heart Association for Personalized Management of Patients with Suspected CAD

Reinforces Role of AI-Powered Quantitative Coronary Plaque Assessment Reinforces Role of AI-Powered Quantitative Coronary Plaque Assessment

3 months ago - GlobeNewsWire

Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease

Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health Service...

4 months ago - GlobeNewsWire

Heartflow to Participate in the Piper Sandler 37th Annual Healthcare Conference

MOUNTAIN VIEW, Calif., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in artificial intelligence (AI) technology for coronary artery disease (CAD), today anno...

4 months ago - GlobeNewsWire

Heartflow Reports Third Quarter 2025 Financial Results

MOUNTAIN VIEW, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in artificial intelligence (AI) technology for coronary artery disease (CAD), today repo...

5 months ago - GlobeNewsWire

Baron Technology Fund: AI Update

The market has recently absorbed a surge of activity around AI infrastructure buildouts. NVIDIA CEO Jensen Huang proclaimed in September that global AI infrastructure spending could total $3 trillion ...

Other symbols: AMDAVGONVDAORCL
5 months ago - Seeking Alpha

AHA 2025: Late-Breaking Data Reinforce the Prognostic Power of AI-Driven Heartflow Plaque Analysis as the Most Clinically Validated Framework for Coronary Risk Stratification

NEW ORLEANS, Nov. 09, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced late-breaking data from the FI...

5 months ago - GlobeNewsWire

Heartflow to Present Late-Breaking Data Advancing AI-Driven Heartflow Plaque Analysis at AHA 2025

MOUNTAIN VIEW, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced it will present new ...

5 months ago - GlobeNewsWire

Heartflow to Report Third Quarter 2025 Financial Results on November 12, 2025

MOUNTAIN VIEW, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced it will release fina...

5 months ago - GlobeNewsWire

New Heartflow PCI Navigator to Equip Interventional Cardiologists with Pre-procedural Insights to Enable PCI Planning

PLAN CALCIUM study to be presented at TCT 2025 conference highlights how AI-powered plaque analysis can inform lesion preparation and calcium modification planning NAVIGATE-PCI registry to enroll appr...

5 months ago - GlobeNewsWire

Heartflow Announces FDA 510(k) Clearance and Launch of Next Generation Heartflow Plaque Analysis Platform

AI-Powered Heartflow Plaque Analysis to be Covered by Cigna Health Plans Nationwide AI-Powered Heartflow Plaque Analysis to be Covered by Cigna Health Plans Nationwide

6 months ago - GlobeNewsWire

Heartflow to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

MOUNTAIN VIEW, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced that members of mana...

7 months ago - GlobeNewsWire

Heartflow, Inc. Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares

MOUNTAIN VIEW, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), a leader in AI technology for coronary artery disease (CAD), today announced the closing of its ups...

8 months ago - GlobeNewsWire

HeartFlow: Investors Put Their Heart In

HeartFlow's AI-driven, non-invasive CAD diagnostic platform addresses a large, growing market with significant clinical need and strong early adoption. The IPO valued HeartFlow at $1.5 billion, equal ...

8 months ago - Seeking Alpha

Heartflow Stock Opens Nearly 50% Above IPO Price in Latest Hot Debut

Medical imaging company Heartflow rose nearly 50% on its first day, joining Firefly, Figma, and Circle as big IPO gainers.

8 months ago - Barrons